{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:11:51Z","timestamp":1784563911591,"version":"3.55.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.abd.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T03:35:21Z","timestamp":1602300921000},"page":"70-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"S1","title":["Consensus on the treatment of vitiligo \u2013 Brazilian Society of Dermatology"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-0002","authenticated-orcid":false,"given":"Gerson","family":"Dellatorre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8203-1772","authenticated-orcid":false,"given":"Daniela Alves Pereira","family":"Antelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4739-9699","authenticated-orcid":false,"given":"Roberta Buense","family":"Bedrikow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3001-0202","authenticated-orcid":false,"given":"Tania Ferreira","family":"Cestari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-0684","authenticated-orcid":false,"given":"Ivonise","family":"Follador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-7569","authenticated-orcid":false,"given":"Daniel Gontijo","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-5765","authenticated-orcid":false,"given":"Caio Cesar","family":"Silva de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2020.05.007_bib0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1755-148X.2008.00511.x","article-title":"Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo","volume":"21","author":"Taieb","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","article-title":"Chemical-induced vitiligo","volume":"35","author":"Harris","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.007_bib0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/pcmr.12681","article-title":"Prevalence of vitiligo in Brazil \u2013 a population survey","volume":"31","author":"Cesar Silva de Castro","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2011.09.011","article-title":"A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population","volume":"65","author":"Silva de Castro","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.abd.2020.05.007_bib0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2019.06.013","article-title":"Family clustering of autoimmune vitiligo results principally from polygenic inheritance of common risk alleles","volume":"105","author":"Roberts","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.abd.2020.05.007_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8(+) T cells in vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.abd.2020.05.007_bib0035","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamadermatol.2019.4483","article-title":"Association of clinical markers with disease progression in patients with vitiligo from China","volume":"156","author":"Zhang","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","article-title":"Current and emerging treatments for vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: an update on pathophysiology and treatment options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1755-148X.2011.00922.x","article-title":"In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial","volume":"25","author":"van Geel","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0060","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archderm.134.12.1532","article-title":"Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","article-title":"Update on skin repigmentation therapies in vitiligo","volume":"22","author":"Falabella","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archderm.1984.01650410073019","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/2229-5178.131071","article-title":"Role of the ACTH test and estimation of a safe dose for high potency steroids in vitiligo: a prospective randomized study","volume":"5","author":"de la Fuente-Garcia","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.abd.2020.05.007_bib0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaad.2010.10.043","article-title":"Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment","volume":"65","author":"Felsten","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2019.07.108","article-title":"The effectiveness of topical calcineurin inhibitors compared with topical corticosteroids in the treatment of vitiligo: a systematic review and meta-analysis","volume":"82","author":"Chang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000065845","article-title":"Repigmentation of vitiligo with topical tacrolimus","volume":"205","author":"Smith","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.05.007_bib0100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases","volume":"51","author":"Silverberg","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0105","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.139.5.571","article-title":"Successful treatment of vitiligo with 0.1% tacrolimus ointment","volume":"139","author":"Travis","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000073099","article-title":"Repigmentation of vitiligo with pimecrolimus cream: a case report","volume":"207","author":"Mayoral","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.05.007_bib0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","article-title":"Topical tacrolimus for treatment of childhood vitiligo in Asians","volume":"29","author":"Kanwar","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0125","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study","volume":"135","author":"Cavalie","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"16","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2020.05.007_bib0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1525-1470.2010.01223.x","article-title":"The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis","volume":"27","author":"McCollum","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000088505","article-title":"Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hairless mouse epidermis","volume":"211","author":"Tran","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.05.007_bib0150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/dth.12384","article-title":"The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial","volume":"29","author":"El Mofty","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2020.05.007_bib0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.abd.2020.05.007_bib0160","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0165","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2310\/7750.2013.12053","article-title":"Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo","volume":"17","author":"Kanwar","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000439563","article-title":"A retrospective study of methylprednisolone mini-pulse therapy combined with narrow-band UVB in non-segmental vitiligo","volume":"232","author":"Lee","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.05.007_bib0180","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2020.05.007_bib0185","first-page":"705","article-title":"Low-dose methotrexate for vitiligo","volume":"16","author":"Garza-Mayers","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0190","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12532","article-title":"Methotrexate for treatment of vitiligo","volume":"30","author":"Abdelmaksoud","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2020.05.007_bib0195","article-title":"A randomized comparative study of the effect of betamethasone oral mini-pulse therapy versus oral azathioprine in progressive non-segmental vitiligo","author":"Patra","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0200","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jdv.14792","article-title":"Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis","volume":"32","author":"Speeckaert","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.05.007_bib0205","article-title":"Antioxidant supplements in combination with phototherapy for vitiligo: a systematic review and meta-analysis of randomized controlled trials","author":"Jung","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.det.2019.08.005","article-title":"Phototherapy for vitiligo","volume":"38","author":"Zubair","year":"2020","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.007_bib0215","first-page":"1309","article-title":"Therapeutic management of vitiligo","volume":"16","author":"Bleuel","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.abd.2020.05.007_bib0220","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.abd.2020.05.007_bib0225","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/phpp.12277","article-title":"Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis","volume":"33","author":"Li","year":"2017","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.abd.2020.05.007_bib0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ajd.12256","article-title":"Vitiligo treatment update","volume":"56","author":"Daniel","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0240","first-page":"160","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Taieb","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2020.05.007_bib0245","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/phpp.12029","article-title":"The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration","volume":"29","author":"Park","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.abd.2020.05.007_bib0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0781.2006.00222.x","article-title":"Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites","volume":"22","author":"Anbar","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.abd.2020.05.007_bib0255","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12480997","article-title":"Role of hair follicles in the repigmentation of vitiligo","volume":"97","author":"Cui","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0260","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2017.0002","article-title":"Phototherapy for vitiligo: a systematic review and meta-analysis","volume":"153","author":"Bae","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0265","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/idoj.IDOJ_310_18","article-title":"What is new in narrow-band ultraviolet-B therapy for vitiligo?","volume":"10","author":"Khanna","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.abd.2020.05.007_bib0270","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/jdv.12870","article-title":"Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan","volume":"29","author":"Chen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.05.007_bib0275","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-4632.2009.03928.x","article-title":"Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area","volume":"48","author":"Welsh","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0280","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.det.2007.04.009","article-title":"New and experimental treatments of vitiligo and other hypomelanoses","volume":"25","author":"Lotti","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.007_bib0285","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40257-015-0151-7","article-title":"The safety and efficacy of narrow band ultraviolet B treatment in dermatology: a review","volume":"16","author":"Sokolova","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2133.2000.03237.x","article-title":"Guidelines for topical PUVA: a report of a workshop of the British photodermatology group","volume":"142","author":"Halpern","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0295","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2133.1994.tb02910.x","article-title":"British Photodermatology Group guidelines for PUVA","volume":"130","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0300","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jaad.2016.10.016","article-title":"Folate and phototherapy: what should we inform our patients?","volume":"77","author":"Zhang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archderm.1991.01680030067008","article-title":"Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis","volume":"127","author":"Stern","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0310","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy","volume":"143","author":"Yones","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0315","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1468-3083.2006.02035.x","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.05.007_bib0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0781.2006.00189.x","article-title":"Narrow band Ultraviolet B 311nm in the treatment of vitiligo: two right-left comparison studies","volume":"22","author":"El Mofty","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.abd.2020.05.007_bib0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clindermatol.2005.10.024","article-title":"Use of the 308-nm excimer laser for psoriasis and vitiligo","volume":"24","author":"Passeron","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0330","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaad.2008.07.053","article-title":"Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review","volume":"60","author":"Nicolaidou","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2133.2012.11008.x","article-title":"A review of monochromatic excimer light in vitiligo","volume":"167","author":"Park","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0340","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3346\/jkms.2005.20.2.273","article-title":"Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study","volume":"20","author":"Hong","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.abd.2020.05.007_bib0345","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311\u2013313nm) in the treatment of vitiligo \u2013 a multicentre controlled study","volume":"21","author":"Casacci","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.05.007_bib0350","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2133.2010.09778.x","article-title":"308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study","volume":"163","author":"Le Duff","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0355","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/09546634.2014.991268","article-title":"Treatment of 308-nm excimer laser on vitiligo: a systemic review of randomized controlled trials","volume":"26","author":"Sun","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2020.05.007_bib0360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40257-015-0164-2","article-title":"Efficacy and safety of 308-nm monochromatic excimer lamp versus other phototherapy devices for vitiligo: a systematic review with meta-analysis","volume":"17","author":"Lopes","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.det.2016.11.003","article-title":"Skin cancer risk (nonmelanoma skin cancers\/melanoma) in vitiligo patients","volume":"35","author":"Rodrigues","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.007_bib0370","first-page":"191","article-title":"Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo","volume":"66","author":"Harrist","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/j.abd.2020.05.007_bib0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555572305306","article-title":"PUVA treatment of vitiligo: a retrospective study of 59 patients","volume":"72","author":"Wildfang","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2020.05.007_bib0380","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2016.12.041","article-title":"The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo","volume":"76","author":"Mohammad","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0385","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1067\/mjd.2002.124618","article-title":"The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis","volume":"47","author":"Stern","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0390","first-page":"S37","article-title":"Standard guidelines of care for vitiligo surgery","volume":"74 Suppl","author":"Parsad","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2020.05.007_bib0395","series-title":"Surgical management of vitiligo","author":"Gupta","year":"2006"},{"key":"10.1016\/j.abd.2020.05.007_bib0400","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaad.2017.01.056","article-title":"Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas","volume":"77","author":"Silpa-Archa","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0405","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2133.2010.10014.x","article-title":"Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus","volume":"163","author":"Van Geel","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0410","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaad.2017.05.027","article-title":"The majority of patients presenting with vitiligo have a clinical sign of activity","volume":"77","author":"Aboul-Fettouh","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-2077.112667","article-title":"Stability in vitiligo: is there a perfect way to predict it?","volume":"6","author":"Parsad","year":"2013","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0420","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0425","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaad.2003.11.085","article-title":"The minigrafting test for vitiligo: validation of a predicting tool","volume":"51","author":"Falabella","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.abd.2020.05.007_bib0430","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0190-9622(95)90131-0","article-title":"The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation","volume":"32","author":"Falabella","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.abd.2020.05.007_bib0435","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bjd.12532","article-title":"Surgical interventions for vitiligo: an evidence-based review","volume":"169","author":"Mulekar","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0974-2077.158439","article-title":"Role of recipient-site preparation techniques and post-operative wound dressing in the surgical management of vitiligo","volume":"8","author":"Al-Hadidi","year":"2015","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0445","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0378-6323.90947","article-title":"Non-cultured epidermal suspension in vitiligo: from laboratory to clinic","volume":"78","author":"Gauthier","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2020.05.007_bib0450","first-page":"289","article-title":"Vitiligo surgical treatment","volume":"8","author":"Dellatorre","year":"2016","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0455","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-4362.2003.01628.x","article-title":"Melanocyte-keratinocyte cell transplantation for stable vitiligo","volume":"42","author":"Mulekar","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0460","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jaad.2011.05.002","article-title":"Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States","volume":"66","author":"Huggins","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0465","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/0019-5154.160482","article-title":"Long-term follow-up and donor site changes evaluation in suction blister epidermal grafting done for stable vitiligo: a retrospective study","volume":"60","author":"Ashique","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0470","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/abd1806-4841.20175700","article-title":"Evaluation of treatment response to autologous transplantation of noncultured melanocyte\/keratinocyte cell suspension in patients with stable vitiligo","volume":"92","author":"Ramos","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0475","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/SCS.0000000000003834","article-title":"Modified technique of cultured epithelial cells transplantation on facial segmental vitiligo","volume":"28","author":"Wu","year":"2017","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0974-2077.79183","article-title":"Autologous non-cultured basal cell-enriched epidermal cell suspension transplantation in vitiligo: Indian experience","volume":"4","author":"Paul","year":"2011","journal-title":"J Cutan Aesthetic Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0485","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2003.12.013","article-title":"Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases","volume":"51","author":"Chen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.06.016","article-title":"Motorized 0.8-mm micropunch grafting for refractory vitiligo: a retrospective study of 230 cases","volume":"79","author":"Bae","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0495","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000018089","article-title":"Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients","volume":"198","author":"Malakar","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.05.007_bib0500","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0974-2077.129977","article-title":"Autologous mini punch grafting: an experience of using motorized power punch in 10 patients","volume":"7","author":"Chandrashekar","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0505","series-title":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Resolu\u00e7\u00e3o CNS\/MS 466. Dezembro","author":"BRASIL","year":"2012"},{"key":"10.1016\/j.abd.2020.05.007_bib0510","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/jdv.15411","article-title":"Six-year follow-up of vitiligo patients successfully treated with autologous non-cultured melanocyte-keratinocyte transplantation","volume":"33","author":"Altalhab","year":"2019","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1016\/j.abd.2020.05.007_bib0515","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/dsu.12444","article-title":"A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo","volume":"40","author":"Zhang","year":"2014","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0520","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/jocd.12759","article-title":"The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios","volume":"18","author":"Tawfik","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0525","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/DSS.0000000000001846","article-title":"Induction of pigmentation through microneedling in stable localized vitiligo patients","volume":"46","author":"Andrade Lima","year":"2020","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.05.007_bib0530","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/jocd.13152","article-title":"Evaluation of the additional effect of topical 5-fluorouracil to needling in the treatment of localized vitiligo","volume":"19","author":"Attwa","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0535","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ced.13056","article-title":"Improvement in moderate to severe vitiligo using a novel combination of 308nm excimer laser and a surgical needling technique","volume":"42","author":"BinSheikhan","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0540","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaad.2017.12.054","article-title":"Efficacy of NB-UVB, microneedling with triamcinolone acetonide, and a combination of both modalities in the treatment of vitiligo: a comparative study","volume":"79","author":"Elshafy Khashaba","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0545","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jocd.12704","article-title":"Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo","volume":"18","author":"Ibrahim","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0550","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.jaad.2018.12.008","article-title":"5-Fluorouracil as an adjuvant therapy along with microneedling in vitiligo","volume":"80","author":"Jha","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0555","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/dth.12383","article-title":"A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo","volume":"29","author":"Korobko","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2020.05.007_bib0560","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jaad.2018.12.066","article-title":"Microneedling with Dermaroller 192 needles along with 5-fluorouracil solution in the treatment of stable vitiligo","volume":"81","author":"Kumar","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0565","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/bjd.17464","article-title":"Comparison of microneedling and full surface erbium laser dermabrasion for autologous cell suspension grafting in nonsegmental vitiligo: a randomized controlled trial","volume":"180","author":"Lagrange","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0570","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jocd.12440","article-title":"Comparison between the efficacy of microneedling combined with 5-fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo","volume":"17","author":"Mina","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0575","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/ijdvl.IJDVL_386_16","article-title":"Efficacy of topical 5% fluorouracil needling in vitiligo","volume":"84","author":"Shashikiran","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2020.05.007_bib0580","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/dth.12363","article-title":"Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB","volume":"29","author":"Stanimirovic","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2020.05.007_bib0585","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.jaad.2016.05.033","article-title":"Needling in unresponsive stable vitiligo","volume":"75","author":"Zawar","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0590","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40257-019-00430-0","article-title":"Childhood vitiligo","volume":"20","author":"Nicolaidou","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0595","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.det.2016.11.011","article-title":"Special considerations in children with vitiligo","volume":"35","author":"Taieb","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.007_bib0600","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/phpp.12382","article-title":"Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy","volume":"34","author":"Raone","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.abd.2020.05.007_bib0605","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0781.2004.00084.x","article-title":"Phototherapy and PUVA photochemotherapy in children","volume":"20","author":"Holme","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.abd.2020.05.007_bib0610","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1525-1470.2011.01683.x","article-title":"Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients","volume":"29","author":"Percivalle","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0615","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2230.2005.01837.x","article-title":"Narrow-band UVB for the treatment of generalized vitiligo in children","volume":"30","author":"Kanwar","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.abd.2020.05.007_bib0620","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0625","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1525-1470.2005.22319.x","article-title":"Useful treatment of vitiligo in 10 children with UV-B narrowband (311nm)","volume":"22","author":"Brazzelli","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0630","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.det.2016.11.003","article-title":"Skin cancer risk (nonmelanoma skin cancers\/melanoma) in vitiligo patients","volume":"35","author":"Rodrigues","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.05.007_bib0635","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pde.12991","article-title":"Treatment of childhood vitiligo using tacrolimus ointment with narrowband ultraviolet B phototherapy","volume":"33","author":"Dayal","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0640","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/archdischild-2015-309522","article-title":"Systematic review of the toxicity of short-course oral corticosteroids in children","volume":"101","author":"Aljebab","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.abd.2020.05.007_bib0645","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0650","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids","volume":"18","author":"van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.abd.2020.05.007_bib0655","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0019-5154.53185","article-title":"Childhood vitiligo: response to methylprednisolone oral minipulse therapy and topical fluticasone combination","volume":"54","author":"Majid","year":"2009","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0660","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes","volume":"43","author":"Bandoli","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.abd.2020.05.007_bib0665","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4103\/ijdvl.IJDVL_650_16","article-title":"Retrospective study on the characteristics and treatment of late-onset vitiligo","volume":"83","author":"Kong","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2020.05.007_bib0670","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0675","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4126","article-title":"A practical approach to the diagnosis and treatment of vitiligo in children","volume":"138","author":"Ezzedine","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.abd.2020.05.007_bib0680","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0685","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s40261-019-00845-x","article-title":"Efficacy of the topical calcineurin inhibitors tacrolimus and pimecrolimus in the treatment of vitiligo in infants under 2 years of age: a randomized","volume":"39","author":"Hu","year":"2019","journal-title":"Open-Label Pilot Study. Clin Drug Investig"},{"key":"10.1016\/j.abd.2020.05.007_bib0690","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1067\/mjd.2002.120576","article-title":"Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well","volume":"46","author":"Cockayne","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0695","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaad.2006.08.017","article-title":"High-potency steroid use in children with vitiligo: a retrospective study","volume":"56","author":"Kwinter","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0700","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2133.2011.10351.x","article-title":"A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo","volume":"165","author":"Ho","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0705","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamadermatol.2016.1009","article-title":"Safety of topical corticosteroids in pregnancy","volume":"152","author":"Chi","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0710","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/ijd.IJD_169_17","article-title":"Use of topical corticosteroids in dermatology: an evidence-based approach","volume":"62","author":"Das","year":"2017","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0715","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/00007890-200012270-00010","article-title":"Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus","volume":"70","author":"Kainz","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.abd.2020.05.007_bib0720","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archderm.136.8.999","article-title":"Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group","volume":"136","author":"Reitamo","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0725","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.0022-202X.2005.23754.x","article-title":"Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis","volume":"125","author":"Rubins","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0730","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.2008.08974.x","article-title":"Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis","volume":"160","author":"Undre","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0735","first-page":"37","article-title":"A study of the prognosis of vitiligo during pregnancy","volume":"5","author":"Delatorre","year":"2013","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0740","first-page":"21","article-title":"Influence of pregnancy on vitiligo activity","volume":"9","author":"Webb","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.05.007_bib0745","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4103\/ijdvl.IJDVL_650_16","article-title":"Retrospective study on the characteristics and treatment of late-onset vitiligo","volume":"83","author":"Kong","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620302361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620302361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:40:52Z","timestamp":1759794052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059620302361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":149,"alternative-id":["S0365059620302361"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2020.05.007","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus on the treatment of vitiligo \u2013 Brazilian Society of Dermatology","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}